Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
36
MNDR Quote, Financials, Valuation and Earnings
Last price:
$1.40
Seasonality move
:
21.96%
Day range:
$1.52 - $1.80
52-week range:
$1.52 - $40.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.14x
P/B ratio:
1.69x
Volume:
986.3K
Avg. volume:
6.6M
1-year change:
-88.2%
Market cap:
$1.9M
Revenue:
$5.8M
EPS (TTM):
-$0.45
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -- | -- | -- | -- |
|
BMGL
Basel Medical Group Ltd.
|
-- | -- | -- | -- | -- |
|
CUPR
Cuprina Holdings (Cayman)
|
-- | -- | -- | -- | -- |
|
GDTC
CytoMed Therapeutics Ltd.
|
$130K | -$0.04 | -- | -- | -- |
|
WVE
Wave Life Sciences Ltd.
|
$7.7M | -$0.31 | -78.95% | -36.52% | $19.80 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
$1.52 | -- | $1.9M | -- | $0.00 | 0% | 0.14x |
|
BMGL
Basel Medical Group Ltd.
|
$1.05 | -- | $19.7M | 294.67x | $0.00 | 0% | 2.31x |
|
CUPR
Cuprina Holdings (Cayman)
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
GDTC
CytoMed Therapeutics Ltd.
|
$1.77 | -- | $20.8M | -- | $0.00 | 0% | 120.01x |
|
WVE
Wave Life Sciences Ltd.
|
$7.49 | $19.80 | $1.3B | -- | $0.00 | 0% | 11.43x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -0.831 | -- | 2.20x |
|
BMGL
Basel Medical Group Ltd.
|
-- | 0.000 | -- | -- |
|
CUPR
Cuprina Holdings (Cayman)
|
-- | 0.000 | -- | -- |
|
GDTC
CytoMed Therapeutics Ltd.
|
-- | -0.681 | -- | -- |
|
WVE
Wave Life Sciences Ltd.
|
12.99% | 1.535 | 1.67% | 2.40x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MNDR
Mobile-health Network Solutions
|
-- | -- | -1223.46% | -1223.46% | -- | -- |
|
BMGL
Basel Medical Group Ltd.
|
-- | -- | -- | -- | -- | -- |
|
CUPR
Cuprina Holdings (Cayman)
|
-- | -- | -- | -- | -- | -- |
|
GDTC
CytoMed Therapeutics Ltd.
|
-- | -- | -- | -- | -- | -- |
|
WVE
Wave Life Sciences Ltd.
|
$5.4M | -$56.4M | -64.6% | -73.8% | -740.71% | -$46.1M |
Mobile-health Network Solutions vs. Competitors
-
Which has Higher Returns MNDR or BMGL?
Basel Medical Group Ltd. has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat Basel Medical Group Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M BMGLBasel Medical Group Ltd.-- -- -- -
What do Analysts Say About MNDR or BMGL?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 20952.63%. On the other hand Basel Medical Group Ltd. has an analysts' consensus of -- which suggests that it could fall by --. Given that Mobile-health Network Solutions has higher upside potential than Basel Medical Group Ltd., analysts believe Mobile-health Network Solutions is more attractive than Basel Medical Group Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 BMGLBasel Medical Group Ltd.0 0 0 -
Is MNDR or BMGL More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Basel Medical Group Ltd. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or BMGL?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Basel Medical Group Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Basel Medical Group Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or BMGL?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Basel Medical Group Ltd. quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than Basel Medical Group Ltd.'s net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Basel Medical Group Ltd.'s PE ratio is 294.67x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.14x versus 2.31x for Basel Medical Group Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.14x -- -- -- BMGLBasel Medical Group Ltd.2.31x 294.67x -- --
-
Which has Higher Returns MNDR or CUPR?
Cuprina Holdings (Cayman) has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat Cuprina Holdings (Cayman)'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M CUPRCuprina Holdings (Cayman)-- -- -- -
What do Analysts Say About MNDR or CUPR?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 20952.63%. On the other hand Cuprina Holdings (Cayman) has an analysts' consensus of -- which suggests that it could fall by --. Given that Mobile-health Network Solutions has higher upside potential than Cuprina Holdings (Cayman), analysts believe Mobile-health Network Solutions is more attractive than Cuprina Holdings (Cayman).
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 CUPRCuprina Holdings (Cayman)0 0 0 -
Is MNDR or CUPR More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Cuprina Holdings (Cayman) has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or CUPR?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Cuprina Holdings (Cayman) offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Cuprina Holdings (Cayman) pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or CUPR?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Cuprina Holdings (Cayman) quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than Cuprina Holdings (Cayman)'s net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Cuprina Holdings (Cayman)'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.14x versus -- for Cuprina Holdings (Cayman). Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.14x -- -- -- CUPRCuprina Holdings (Cayman)-- -- -- --
-
Which has Higher Returns MNDR or GDTC?
CytoMed Therapeutics Ltd. has a net margin of -- compared to Mobile-health Network Solutions's net margin of --. Mobile-health Network Solutions's return on equity of -1223.46% beat CytoMed Therapeutics Ltd.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M GDTCCytoMed Therapeutics Ltd.-- -- -- -
What do Analysts Say About MNDR or GDTC?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 20952.63%. On the other hand CytoMed Therapeutics Ltd. has an analysts' consensus of -- which suggests that it could grow by 182.49%. Given that Mobile-health Network Solutions has higher upside potential than CytoMed Therapeutics Ltd., analysts believe Mobile-health Network Solutions is more attractive than CytoMed Therapeutics Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 GDTCCytoMed Therapeutics Ltd.0 0 0 -
Is MNDR or GDTC More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison CytoMed Therapeutics Ltd. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MNDR or GDTC?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoMed Therapeutics Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. CytoMed Therapeutics Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or GDTC?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than CytoMed Therapeutics Ltd. quarterly revenues of --. Mobile-health Network Solutions's net income of -- is lower than CytoMed Therapeutics Ltd.'s net income of --. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while CytoMed Therapeutics Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.14x versus 120.01x for CytoMed Therapeutics Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.14x -- -- -- GDTCCytoMed Therapeutics Ltd.120.01x -- -- --
-
Which has Higher Returns MNDR or WVE?
Wave Life Sciences Ltd. has a net margin of -- compared to Mobile-health Network Solutions's net margin of -707.83%. Mobile-health Network Solutions's return on equity of -1223.46% beat Wave Life Sciences Ltd.'s return on equity of -73.8%.
Company Gross Margin Earnings Per Share Invested Capital MNDRMobile-health Network Solutions-- -- $4.1M WVEWave Life Sciences Ltd.70.69% -$0.32 $152.2M -
What do Analysts Say About MNDR or WVE?
Mobile-health Network Solutions has a consensus price target of --, signalling upside risk potential of 20952.63%. On the other hand Wave Life Sciences Ltd. has an analysts' consensus of $19.80 which suggests that it could grow by 164.35%. Given that Mobile-health Network Solutions has higher upside potential than Wave Life Sciences Ltd., analysts believe Mobile-health Network Solutions is more attractive than Wave Life Sciences Ltd..
Company Buy Ratings Hold Ratings Sell Ratings MNDRMobile-health Network Solutions0 0 0 WVEWave Life Sciences Ltd.13 1 0 -
Is MNDR or WVE More Risky?
Mobile-health Network Solutions has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Wave Life Sciences Ltd. has a beta of -1.719, suggesting its less volatile than the S&P 500 by 271.88%.
-
Which is a Better Dividend Stock MNDR or WVE?
Mobile-health Network Solutions has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Wave Life Sciences Ltd. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mobile-health Network Solutions pays -- of its earnings as a dividend. Wave Life Sciences Ltd. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MNDR or WVE?
Mobile-health Network Solutions quarterly revenues are --, which are smaller than Wave Life Sciences Ltd. quarterly revenues of $7.6M. Mobile-health Network Solutions's net income of -- is lower than Wave Life Sciences Ltd.'s net income of -$53.9M. Notably, Mobile-health Network Solutions's price-to-earnings ratio is -- while Wave Life Sciences Ltd.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mobile-health Network Solutions is 0.14x versus 11.43x for Wave Life Sciences Ltd.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MNDRMobile-health Network Solutions0.14x -- -- -- WVEWave Life Sciences Ltd.11.43x -- $7.6M -$53.9M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 8
SMX (Security Matters) Plc [SMX] is down 60.69% over the past day.
Buy
62
PRAX alert for Dec 8
Praxis Precision Medicines, Inc. [PRAX] is up 7.84% over the past day.
Sell
13
PSN alert for Dec 8
Parsons Corp. [PSN] is down 5.82% over the past day.
